3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy

Alessandro Satriano1, Bobak Heydari2,3, Namrata Guron1

  • 1Division of Cardiology, Department of Cardiac Sciences, Stephenson Cardiac Imaging Centre, University of Calgary, Calgary, Canada.

Insights

Hypertrophic cardiomyopathy (HCM) shows reduced principal strain in non-enhanced myocardium. This strain is further diminished in patients with extensive late gadolinium enhancement, indicating potential prognostic value.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biophysics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by myocardial disarray, hypertrophy, and fibrosis.
  • Reduced global longitudinal strain and late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) are linked to adverse prognosis in HCM.
  • Current assessments often focus on LGE, but strain characteristics of non-enhanced myocardium warrant further investigation.

Purpose of the Study:

  • To evaluate 3D principal and conventional strain characteristics in the non-enhanced myocardium of patients with HCM.
  • To compare strain parameters between HCM patients and healthy controls.
  • To investigate the association between strain measures in non-enhanced myocardium and indicators of disease severity like LGE and left ventricular (LV) mass.

Main Methods:

  • Cardiac magnetic resonance imaging (CMR) was performed on 51 HCM patients and 38 healthy controls.
  • 3D principal and conventional strain analysis (longitudinal, circumferential, radial) was conducted on the non-enhanced myocardial segments.
  • Statistical analyses were used to compare strain parameters between groups and correlate them with clinical and imaging variables, including indexed LV mass and LGE extent.

Main Results:

  • Principal strain was significantly reduced in the non-enhanced myocardium of HCM patients compared to controls (maximum principal: 51.5 ± 23.7% vs. 75.1 ± 21.4%, P < 0.0001).
  • Principal strain was incrementally reduced in HCM patients with extensive global LGE (≥15%), along with longitudinal and circumferential strain.
  • All strain measures in non-enhanced myocardium were independently associated with indexed LV mass after adjustment.

Conclusions:

  • 3D principal strain of non-enhanced myocardium is significantly reduced in HCM patients.
  • This reduction is incrementally worse in patients with more extensive LGE, suggesting strain analysis provides valuable insights beyond LGE.
  • Comprehensive strain assessment, including principal strain of non-enhanced myocardium, may enhance routine CMR evaluation of HCM patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
451
Three-Dimensional Analysis of Strain01:29

Three-Dimensional Analysis of Strain

Three-dimensional strain analysis is crucial for understanding how materials deform under stress, particularly in elastic, homogeneous materials. This method employs principal stress axes to simplify complex stress states into more understandable forms. Subjected to stress, a small cubic element within a material either expands or contracts along these axes, transforming into a rectangular parallelepiped. This transformation effectively illustrates the material's deformation. The principal...
602
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
509
Global Climate Change01:50

Global Climate Change

Throughout its ~4.5 billion year history, the Earth has experienced periods of warming and cooling. However, the current drastic increase in global temperatures is well outside of the Earth’s cyclic norms, and evidence for human-caused global climate change is compelling. Paleoclimatology, the study of ancient climate conditions, provides ample evidence for human-caused global climate change by comparing recent conditions with those in the past.
28.8K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
496